SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028221
Filing Date
2021-11-12
Accepted
2021-11-12 16:56:50
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1565503
2 ex10-1.htm EX-10.1 78136
3 ex31-1.htm EX-31.1 15191
4 ex32-1.htm EX-32.1 7973
  Complete submission text file 0001493152-21-028221.txt   7196810

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ppcb-20210930.xsd EX-101.SCH 55708
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ppcb-20210930_cal.xml EX-101.CAL 54258
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ppcb-20210930_def.xml EX-101.DEF 225959
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ppcb-20210930_lab.xml EX-101.LAB 449727
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ppcb-20210930_pre.xml EX-101.PRE 329401
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1078911
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 211404553
SIC: 2834 Pharmaceutical Preparations